IL-1β can promote the release of the intracellular domain of IL-1R2 (icd-IL-1R2), and the increased IL-1R2 in breast cancer can promote the self-renewal and proliferation of breast tumor cells16. Here, IL1R2 is linked to breast carcinoma.